Non-invasive ventilation using a novel ventilator and non-vented full-face mask for patients with respiratory failure during the COVID-19 pandemic: Report of three cases

Minami, Takuma; Kai, Shinichi; Tanaka, Tomoharu; Ito, Isao; Kato, Genta; Nagao, Miki; Date, Hiroshi; Hirai, Toyohiro; Ohtsuru, Shigeru; Chin, Kazuo

doi:10.1016/j.resinv.2022.03.005

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The use of noninvasive respiratory support therapies has evolved over time during the pandemic. In the beginning, the scarcity of noninvasive respiratory support devices prompted the repurposing of existing continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) machines [6][7][8]. Noninvasive respiratory support therapies became the first-line intervention for COVID-19-associated AHRF as experience was gained about its efficacy and safety [9] and manufacturers increased production [10].…”

Section: Introductionmentioning

confidence: 99%

Lessons from COVID-19 in the management of acute respiratory failure

Crimi

Murphy

Patout

et al. 2023

Breathe

View full text Add to dashboard Cite

Accumulated evidence supports the efficacy of noninvasive respiratory support therapies in coronavirus disease 2019 (COVID-19)-related acute hypoxaemic respiratory failure, alleviating admissions to intensive care units. Noninvasive respiratory support strategies, including high-flow oxygen therapy, continuous positive airway pressureviamask or helmet and noninvasive ventilation, can be alternatives that may avoid the need for invasive ventilation. Alternating different noninvasive respiratory support therapies and introducing complementary interventions, like self-proning, may improve outcomes. Proper monitoring is warranted to ensure the efficacy of the techniques and to avoid complications while supporting transfer to the intensive care unit. This article reviews the latest evidence on noninvasive respiratory support therapies in COVID-19-related acute hypoxaemic respiratory failure.

show abstract